Table 4.
Correlation between AT-1R expression and selected markers of vascular density (CD31, Lyve-1, D2-40)
| Marker | Number of cases (%) | AT-1R—Number (%) | p | |
|---|---|---|---|---|
| IRS 0-4 | IRS 6-12 | |||
| CD31 Intra | ||||
| ≤ 4 | 24 (23.5) | 8 (33.3) | 16 (66.7) | 0.4475 |
| > 4 | 78 (76.5) | 20 (25.6) | 58 (74.4) | |
| CD31 Peri | ||||
| ≤ 6 | 44 (43.1) | 14 (31.8) | 30 (68.2) | 0.5021 |
| > 6 | 58 (56.9) | 14 (24.1) | 44 (75.9) | |
| Lyve-1 Intra | ||||
| ≤ 1 | 96 (94.1) | 27 (28.1) | 69 (71.9) | 0.3773 |
| > 1 | 6 (5.9) | 1 (16.7) | 5 (83.3) | |
| Lyve-1 Peri | ||||
| ≤ 4 | 77 (75.5) | 19 (24.7) | 58 (75.3) | 0.3068 |
| > 4 | 25 (24.5) | 19 (76.0) | 6 (14.0) | |
| D2-40 Intra | ||||
| ≤ 2 | 51 (50.0) | 11 (21.6) | 40 (78.4) | 0.2676 |
| > 2 | 51 (50.0) | 17 (33.3) | 34 (66.7) | |
| D2-40 Peri | ||||
| ≤ 4 | 52 (51.0) | 12 (23.1) | 40 (76.9) | 0.3733 |
| > 4 | 50 (49.0) | 16 (32.0) | 34 (68.0) | |
Intra—intratumoural vessels, Peri—peritumoural vessels